German deeptech startup NanoStruct has raised €2.6 million in Seed funding to commercialise a sensor chip platform that compresses pathogen detection in food from several days to a few hours. The round was led by High-Tech Gründerfonds (HTGF), Bayern Kapital, and the AUXXO Female Catalyst Fund.
The detection gap inside the food supply chain
Conventional microbial testing relies on culturing bacteria, a process that can take three to five days. In practice, that means contaminated batches frequently reach distribution centres, and sometimes consumers, before laboratory results return. Recalls, when they happen, are reactive rather than preventive.
NanoStruct’s pitch is structural. By collapsing the testing window to a single shift, manufacturers can hold product before it ships rather than chase it through retail networks. The company combines nanostructured optical sensors with biotechnology and machine-learning classification to identify dangerous pathogens within hours rather than days.
Who is funding it
The Seed round brings together three investors with overlapping but distinct mandates: HTGF, a seed-stage public-private fund; Bayern Kapital, the Bavarian state venture arm; and AUXXO, a fund focused on backing female founders. NanoStruct was spun out of Julius-Maximilians-Universität Würzburg and co-founded by Dr Henriette Maaß, Enno Krauss, and Kai Leibfried, with Maaß serving as CEO.
The capital builds on earlier non-dilutive support from the German Federal Ministry for Economic Affairs and Energy and the European Union, a typical financing stack for European deeptech, where public grants de-risk the laboratory phase before private capital takes over commercialisation.
Dr Stephan Ruck, Investment Analyst at HTGF, described the company’s sensor work as a technological breakthrough and pointed to its network in the target market and its team as decisive factors in the investment.
Why the regulatory backdrop matters
The commercial logic tracks a regulatory one. Food safety authorities across the EU and beyond have been pushing testing burdens further upstream toward producers, raising the cost of slow detection and the value of fast detection. Continuous, in-line monitoring is increasingly preferred to batch sampling because it shortens the window in which contaminated product can move through the supply chain undetected.
That regulatory drift creates a predictable market. Every additional compliance requirement raises the price of slow testing and the value of fast testing. NanoStruct is positioning itself at exactly that pressure point.
Beyond food
The platform’s underlying chemistry is industry-agnostic. NanoStruct says the same sensor architecture can be applied to veterinary diagnostics, human diagnostics, and bacterial monitoring in sensitive production environments such as pharmaceutical cleanrooms, biotech fermentation, and water systems. Food is the entry market because the regulatory pull is strongest and the procurement cycles are shortest.
The broader pattern is familiar. Industrial AI and sensing startups are increasingly being valued less on their immediate vertical and more on the optionality of their platform. Silicon Canals has previously covered adjacent moves, including Swiss firm Cerrion’s €15.6M round targeting AI-driven defect detection on factory lines, and NutriUnited’s €8.5M raise to consolidate craft food production in Germany.
The structural read
The food industry’s testing infrastructure was designed for a slower, more local supply chain. Same-day pathogen detection is the kind of incremental-sounding innovation that quietly rewires economics, shifting recall costs, insurance premiums, and producer liability. The €2.6 million NanoStruct just raised is small. The category it is opening is not.
Feature image by Daria on Pexels
